Moderna starts trial of Omicron-specific COVID vaccine booster
Moderna says it will study its Omicron-specific booster in adults aged 18 years and older.Moderna says it will study its Omicron-specific booster in adults aged 18 years and older.Moderna says it will study its Omicron-specific booster in adults aged 18 years and older.External Content
| Source | RSS or Atom Feed |
| Feed Location | https://www.aljazeera.com/xml/rss/all.xml |
| Feed Title | Al Jazeera – Breaking News, World News and Video from Al Jazeera |
| Feed Link | https://www.aljazeera.com/ |
| Feed Copyright | © 2025 Al Jazeera Media Network |
| Reply | 0 comments |